Ajanta Pharma Limited (BOM:532331)
India · Delayed Price · Currency is INR 2,910.20
-114.30 (-3.78%)
At close: May 29, 2026
Ajanta Pharma Market Cap
Ajanta Pharma has a market cap or net worth of 366.05 billion as of June 1, 2026. Its market cap has increased by 15.49% in one year.
Market Cap
366.05B
Enterprise Value
362.00B
Revenue
54.53B
Ranking
n/a
PE Ratio
34.66
Stock Price
2,910.20
Market Cap Chart
Since April 1, 2002, Ajanta Pharma's market cap has increased from 565.80M to 366.05B, an increase of 64,595.81%. That is a compound annual growth rate of 30.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 365.78B | 5.78% |
| Dec 31, 2025 | 345.80B | -5.57% |
| Dec 31, 2024 | 366.20B | 39.58% |
| Dec 29, 2023 | 262.36B | 68.96% |
| Dec 30, 2022 | 155.28B | -19.73% |
| Dec 31, 2021 | 193.46B | 36.89% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Dr. Reddy's Laboratories | 1.08T |
| Lupin | 1.03T |
| Abbott India | 568.95B |
| GlaxoSmithKline Pharmaceuticals | 374.17B |
| J. B. Chemicals & Pharmaceuticals | 343.68B |
| AstraZeneca Pharma India | 218.11B |
| Granules India | 191.37B |
| Rubicon Research | 165.67B |